Armenian National Registry of Myocardial Infarction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-12-01

Study Completion Date

2025-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a national, multicenter prospective observational study of patients presenting to hospitals in Armenia with STEMI diagnosis.

The main questions it aims to answer are:

* Determine the rate of in-hospital mortality for the patients with STEMI admitted to the participating hospitals.
* Compare short and long-term CV and all-cause mortality and hospitalization.
* Determine how professional guidelines are followed in real-world situations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Although the state program on primary percutaneous coronary intervention in ST elevated myocardial infarction, which was launched in 2015 helped to drastically decrease STEMI mortality rates, patients who had survived usually develop heart failure (HF) which leads to increased economic burden for the Armenian healthcare system.

The total duration of the study will be 24 months. The target number of the inclusion is 2500 patients. The follow-up period for enrolled patients will be 12 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ST Elevation Myocardial Infarction

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

STEMI Myocardial infarction acute coronary syndrome CV mortality biobanking

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No specific intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adult patient (≥ 18 years of age),
2. Admitted to the participating centers for a STEMI within 48 hours of symptom onset: characterized by a rise and fall of cardiac markers (troponins) together with ST elevation in at least two contagious leads or LBBB.
3. Have given signed informed consent to participate in the study.

1. MI occurring ≤ 48 hours after PCI or CABG
2. The patient or the legal representative refused to sign the informed consent

Exclusion Criteria

Withdrawal of the informed consent

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hamlet G Hayrapetyan, Prof.

Role: PRINCIPAL_INVESTIGATOR

Armenian Cardiologists Association

Reach out to these primary contacts for questions about participation or study logistics.

Hamlet G Hayrapetyan, Prof.

Role: CONTACT

Phone: +37493555050

Email: [email protected]

Hripsime V Poghosyan, Dr.

Role: CONTACT

Phone: +37477234994

Identifier Type: -

Identifier Source: org_study_id

Armenian National Registry of Myocardial Infarction

Study Results

Basic Information

Brief Summary

Detailed Description

Conditions

Keywords

Study Design

Interventions

No specific intervention

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Sponsors

Santé Arménie French-Armenian Research Center

Armenian Cardiologists Association

Responsible Party

Principal Investigators

Hamlet G Hayrapetyan, Prof.

Locations

Vanadzor Medical Center

Gyumri Medical Center

French-Armenian Cardiovascular Center

Heratsi Hospital Complex N1

Erebouni Medical Center

Aramyants Medical Center

Armenia Medical Center

Astghik Medical Center

Best Life Medical Center

Nork Marash Medical Center

Shengavit Medical Center

Surb Grigor Lusavorich Medical Center

Yerevan Scientific Medical Center

Countries

Central Contacts

Hamlet G Hayrapetyan, Prof.

Hripsime V Poghosyan, Dr.

Facility Contacts

Inga Hovhannisyan

Arthur Stepanyan

Shahane Musayelyan

Hamayak S Sisakyan

Hamlet G Hayrapetyan

Narek Atoyan

Mayranush Drambyan

Zara Kartoyan

Serob Manukian

Mikael Adamyan

Tigran Astvatsatryan

Irina Hovhannisyan

Hovhannes Kzhdryan

Related Links

Other Identifiers

ACA-2023001